The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders

European Journal of Heart Failure

Volumn 11, Issue 12, 2009, Pages 1189-1194

  Frankenstein, Lutz ^a   Zugck, Christian ^a   Nelles, Manfred ^a   Schellberg, Dieter ^a   Katus, Hugo A ^a   Remppis, B Andrew ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Heart failure; Natriuretic peptides; Obesity; Obesity paradox; Survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; PROGNOSIS; REGRESSION ANALYSIS;

EID: 72949096793     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp150     Document Type: Article

References (28)

1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-313.
2. Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol 2006;98:944-948.
3. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-1053.
4. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003;9:29-35.
5. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J 2001;22:1318-1327.
6. Alla F, Briançon S, Juillière Y, Mertes PM, Villemot JP, Zannad F. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000;139:895-904.
7. Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibaek M, Burchardt H, Akkan D, Thune JJ, Køber L, DIAMOND study group. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005;26:58-64.
8. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, SwedbergK,Michelson EL, Granger CB, McMurray JJ, Solomon SD, CHARM Investigators. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan inHeart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;116:627-636. (Pubitemid 47356347)
9. Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 2006;152: 1071-1076.
10. Rivera M, Cortés R, Salvador A, Bertomeu V, de Burgos FG, Payá R, Portolés M, Taléns-Visconti R, Martinez-Dolz L, Valero R, Sevilla B, Climent V. Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 2005;7:1168-1170.
11. Frankenstein L, Remppis A, Nelles M, Schaelling B, Schellberg D, Katus H, Zugck C. Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 2008;29:2634-2640.
12. Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail 2004;6:359-363.
13. Remme WJ, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 2002;4:11-22.
14. Hess G, Moecks J, Zdunek D. N-terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders. Z Kardiol 2005;94:247-254.
15. Lin D, Wei L, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993;80:557-572.
16. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990;77:147-160.
17. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006;47:85-90.
18. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL Jr. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 2007;167: 400-407.
19. Mehta LH, Roth GS. Caloric Restriction and Longevity. Ann NY Acad Sci 2009; 1172:28-33.
20. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med 2004;36: 518-529.
21. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165: 55-61.
22. Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 2005;150:1233-1239.
23. Sagar UN, Ahmed MM, Adams S, Whellan DJ. Does body mass index really matter in the management of heart failure?: a review of the literature. Cardiol Rev 2008;16:124-128.
24. Strandberg TE, Strandberg AY, Salomaa VV, Pitkälä KH, Tilvis RS, Sirola J, Miettinen TA. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. Eur Heart J 2009;30: 1720-1727.
25. von Haehling S, Horwich TB, Fonarow GC, Anker SD. Tipping the scale: heart failure, body mass index, and prognosis. Circulation 2007;116:588-590.
26. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007;12:23-36.
27. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides 2005;26:944-956.
28. Anker SD, John M, Pedersen PU, Raguso C, Cicoira M, Dardai E, Laviano A, Ponikowski P, Schols AM, DGEM (German Society for Nutritional Medicine), Becker HF, Böhm M, Brunkhorst FM, Vogelmeier C, ESPEN (European Society for Parenteral Enteral Nutrition). ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr 2006;25:311-318. (Pubitemid 43832527)